Abstract
Tumor necrosis factor/cachectin (TNF) is a central mediator of the host response (Beutler and Cerami 1986). It exerts endocrine, paracrine, and autocrine control of inflammatory responses (Sherry and Cerami 1988) and has been implicated in the pathogenesis of bacterial, parasitic, and viral infections and neoplastic disease. As one of the major secretory products of macrophages, TNF has been shown to play an important endocrine role in the pathogenesis of gram negative endotoxic shock (Beutler et al. 1985), cachexia associated with chronic disease (Tracey et al. 1988, Oliff et al. 1987), meningococcal septicemia (Waage et al. 1987), cerebral malaria (Grau et al. 1987), graft vs. host disease (Piguet et al. 1987), and cancer cachexia (Aderka et al. 1985, Balk-will et al. 1987). TNF can also be viewed as an autocrine immunomodulator, because it acts on the macrophage, the cell of principal origin (Philip and Epstein 1986). The view of TNF as a paracrine mediator stems from its local, tissue-specific effects. Endothelial cells respond to TNF (Pober 1988). They express specific binding sites for TNF (Nawroth et al. 1986) and respond with a dramatic change of their physiologic properties to TNF.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aderka D, Fisher S, Levo Y, Holtman H, Hahn T, Wallach D (1985) Cachectin/ tumor necrosis factor production by cancer patients. Lancet 2: 1190
Balkwill F, Burke F, Talbot D, Tavernier J, Osborne R, Naylor S, Durbin H, Fiers W (1987) Evidence for tumor necrosis factor/cachectin production in. cancer. Lancet 2: 1229
Beutler B, Milsark IW, Cerami A (1985) Passive immunization against cachectin/ tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229: 869–871
Beutler B, Cerami A (1986) Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature 320: 584–588
Brett J, Gerlach H, Nawroth P, Steinberg S, Godman G, Stern D (1989) Tumor necrosis factor/cachectin increases permeability of endothelial monolayers by a mechanism involving regulatory G proteins. J Exp Med 169: 1977
Clauss M, Murray C, Vianna M, de Waal R, Thurston G, Nawroth P, Gerlach H, Bach R, Famiìletti PC, Stern D (1990) A polyp q tide factor produced by fibrosarcoma cells that induces endothelial cell tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectin. J Biol Chem, in press
Gerlach H, Lieberman H, Bach R, Godman G, Brett J, Stern D (1989) Enhanced responsiveness of endothelium in the growing/motile state to tumor necrosis factor/cachectin. J Exp Med 170: 913–931
Grau GE, Fajardo LF, Piguet PF, Allet B, Lambert PH, Vassalli P (1987) Tumor necrosis factor/cachectin as an essential mediator in murine cerebral malaria. Science 237: 1210–1212
Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N (1987) Macrophage-induced angiogenesis is mediated by tumor necrosis factor alpha. Nature 329: 630–632
Nawroth PP, Bank I, Handley D, Cassimeris J, Chess L, Stern DM (1986) Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin I. J Exp Med 163: 1363–1375
Nawroth PP, Stern DM (1986) Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 163: 740–745
Nawroth P, Handley D, Matsueda G, de Waal R, Gerlach H, Blohm D, Stern D (1988) Tumor necrosis factor/cachectin-induced intrasvascular fibrin formation in meth-A fibrosarcomas. J Exp Med 168: 637–647
Oliff A, Defeo-Jones D, Boyer M, Martinez D, Kiefer D, Vuocolo G, Wolfe A, Socher SH (1987) Tumors secreting human TNF/cachectin induce cachexia in mice. Cell 50: 555–563
Philip R, Epstein LB (1986) Tumor necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin I. Nature 323: 86–89
Piguet PF, Grau GE, Allet B, Vassalli A (1987) Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft vs. host disease. J Exp Med 166: 1280–1289
Pober JS (1988) Cytokine-mediated activation of vascular endothelium. Am J Pathol 133: 426–433
Sherry B, Cerami A (1988) Cachectin/tumor necrosis factor exerts endocrine, paracrine and autocrine control of inflammatory response. J Cell Biol 107: 1269–1277
Tracey KJ, Wei H, Manogue KR, Fong Y, Hesse DG, Nguyen HT, Kuo C, Beutler B, Cotran RS, Cerami A, Lowry SF (1988) Cachectin/tumor necrosis factor induces cachexia, anemia and inflammation. J Exp Med 167: 1211–1227
Waage A, Halstensen A, Espevik T (1987) Association between tumor necrosis factor in serum and fetal outcome in patients with meningococcal disease. Lancet 2: 355–357
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Nawroth, P. et al. (1990). Cytokine Induced Stimulation of Endothelial Cells in Vitro. In: Harenberg, J., Heene, D.L., Stehle, G., Schettler, G. (eds) New Trends in Haemostasis. Veröffentlichungen aus der Geomedizinischen Forschungsstelle der Heidelberger Akademie der Wissenschaften, vol 1990 / 1990/3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84318-1_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-84318-1_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-53275-0
Online ISBN: 978-3-642-84318-1
eBook Packages: Springer Book Archive